The Pittet Lab

We aim to acquire missing knowledge to find better ways to fight cancer. Our areas of expertise are immunology and immunotherapy.

[Nik Joshi @Joshilabyale]

“In other words, DCs are the ‘best supporting actors’ of anti-tumor immunity.”

I guess that makes the T cell Marlon Brando!?!

“I'm gonna make this tumor cell an offer he can't refuse.“

[The Pittet Lab @PittetLab]

Happy to share a link to our recent review of dendritic cells in cancer, written together with the great @MempelThorsten @csgarrix and @DiPilatoMauro.

Here is a link giving full access to the paper: https://t.co/6kYRf6XwoU

[ACIR @ACIR_org]

Bill and Wirapati et al. @RubenBill5 asked if common TME cellular processes control complex and variable patient outcomes. https://t.co/TqNDvxbvfd  @PittetLab

[Cancer Discovery @CD_AACR]

Read Cancer Discovery's #ResearchWatch:
CXCL9:SPP1 Macrophage Polarity Is Linked to Clinical Outcome in Cancer, summarizing the work of @RubenBill5, @MikaelPittet, @PittetLab et al.
https://t.co/oT9SrxbZuM
@Ludwig_Cancer @OncoUNILCHUV

[The Pittet Lab @PittetLab]

9/ 😀📚 If you're hungry for more insights into how patient variation may help us unravel the complexities of cancer, don't miss the full publication here: https://t.co/94ScYEro0h

[The Pittet Lab @PittetLab]

📢 Research Alert! 🧬🔬 🩺 We are super excited that our latest study, led by the great @RubenBill5 & Asa Wirapati, is out: https://t.co/94ScYEro0h
We set out to shed some light on the tumor microenvironment and its impact on cancer progression.
🧵

[The Pittet Lab @PittetLab]

8/ 🙌 Of course, it takes a village to conduct a study like this, so a hearty thank you, and bravo, to all the clinicians, nurses, researchers, bioinformaticians, technicians and many more, who made this study possible.

[The Pittet Lab @PittetLab]

Congratulations Johanna!

[Janduslab @janduslab]

📣 📣 Do you leave close to Geneva and want to participate in an out-of-the box Virtual Reality-based neuroimmunology project? Contact us! We count on you 😊! @snsf_ch Sinergia, @LabMyspace @miupasteur

[The Pittet Lab @PittetLab]

What a fantastic study!

[Jan Böttcher @JBoettcherLab]

We are thrilled that our recent study lead by @BayerlFelix is out in @ImmunityCP today. We addressed the question how cDC1 dysfunction is regulated in tumors and to which extent this contributes to cancer immune evasion. It is Open Access!👇
https://t.co/Kjm87tegxm

A short 🧵:

[Harvard University @Harvard]

The findings suggest that researchers may be able to manipulate neutrophils to make cancer therapies more effective https://t.co/1nYaqMCB70

[The Pittet Lab @PittetLab]

@Casanova_Acebes Thank you so much. This means a lot!

[The Pittet Lab @PittetLab]

Thank you also to Ann Ager for discussing both papers here: https://t.co/MwJK7C2oqi

[The Pittet Lab @PittetLab]

❔What is special about an immune system that successfully attacks tumors, compared to one that doesn’t?

Our new study in @CellCellPress led by @jgungabeesoon, @Nich and @Mate_Kiss_ aimed to address this question. A joint work with the great @KleinLabHMS

https://t.co/Mhi4A7QdfR

[The Pittet Lab @PittetLab]

👉 We also want to advertize a related paper by the team of @merghout and @wolchokj, published in the same issue, which reveals additional insights about the role of neutrophils in mediating effective cancer immunotherapy.
👉 https://t.co/quJw8SIfGZ